www.industrytap.com

Mashup Score: 12

A New Dawn in HIV Prevention: FDA Approves Twice-Yearly Shot With Near-Perfect Success - Industry Tap - 2 day(s) ago

A New Dawn in HIV Prevention: FDA Approves Twice-Yearly Shot With Near-Perfect Success – Industry Tap

Source: www.industrytap.com

Categories: General Medicine News, Partners & KOLs

Tweet Tweets with this article
- MonicaGandhi9
  
  WHO guidelines out for Lenacapavir for PrEP and CDC guidelines coming. Exciting @NIHDirector_Jay to see this drug out. Okay, Gilead charging $14,109 a dose in the US ($28K a year) - let's advocate to bring that price down https://t.co/Rhx57JQhgC https://t.co/EWEqvpSVHZ